HCV Enters the Twenty-First Century
- 21 December 2012
- journal article
- Published by Springer Nature in Current Infectious Disease Reports
- Vol. 15 (1) , 52-60
Abstract
Almost one-third of Americans infected with human immunodeficiency virus (HIV) and 7 million worldwide are coinfected with hepatitis C virus (HCV). The principal route of HCV spread in the US is injection drug use but there are recent reports of outbreaks of acute HCV infection among HIV-infected men who have sex with men. With increased survival as a result of highly active antiretroviral therapy, HCV-associated liver disease has become a leading cause of death in HIV-infected individuals. Currently, telaprevir and boceprevir, both NS3/NS4A inhibitors that significantly improve sustained response when added to pegylated interferon and ribavirin, are approved only for HCV monoinfection. The optimal combination of agents, therapy durations and the timing of treatment remain major challenges in coinfected patients.Keywords
This publication has 96 references indexed in Scilit:
- Hepatitis C and HIV Co-Infection: New Drugs in Practice and in the PipelineCurrent HIV/AIDS Reports, 2012
- Management of Patients Coinfected With HCV and HIV: A Close Look at the Role for Direct-Acting AntiviralsGastroenterology, 2012
- Review and management of drug interactions with boceprevir and telaprevirHepatology, 2012
- Chronic Hepatitis C InfectionNew England Journal of Medicine, 2011
- Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptorVirology, 2009
- A genome-wide genetic screen for host factors required for hepatitis C virus propagationProceedings of the National Academy of Sciences, 2009
- Hepatitis C virus NS2 is a protease stimulated by cofactor domains in NS3Proceedings of the National Academy of Sciences, 2009
- Human occludin is a hepatitis C virus entry factor required for infection of mouse cellsNature, 2009
- Claudin-1 is a hepatitis C virus co-receptor required for a late step in entryNature, 2007
- Cellular glycosaminoglycans and low density lipoprotein receptor are involved in hepatitis C virus adsorptionJournal of Medical Virology, 2002